Your browser doesn't support javascript.
loading
The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations.
Helderman, Noah C; Bajwa-Ten Broeke, Sanne W; Morreau, Hans; Suerink, Manon; Terlouw, Diantha; van der Werf-' T Lam, Anne-Sophie; van Wezel, Tom; Nielsen, Maartje.
Afiliação
  • Helderman NC; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Bajwa-Ten Broeke SW; Department of Clinical Genetics, UMC Groningen, the Netherlands.
  • Morreau H; Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Suerink M; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Terlouw D; Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.
  • van der Werf-' T Lam AS; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands.
  • van Wezel T; Department of Pathology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Nielsen M; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: m.nielsen@lumc.nl.
Crit Rev Oncol Hematol ; 163: 103338, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34044097
ABSTRACT
Lynch syndrome (LS) is a hereditary cancer syndrome that accounts for 3% of all new colorectal cancer (CRC) cases. Patients carry a germline pathogenic variant in one of the mismatch repair (MMR) genes (MLH1, MSH2, MSH6 or PMS2), which encode proteins involved in a post-replicative proofreading and editing mechanism. The clinical presentation of LS is highly heterogeneous, showing high variability in age at onset and penetrance of cancer, which may be partly attributable to the molecular profiles of carcinomas. This review discusses the frequency of alterations in the WNT/B-CATENIN, RAF/MEK/ERK and PI3K/PTEN/AKT pathways identified in all four LS subgroups and how these changes may relate to the 'three pathway model' of carcinogenesis, in which LS CRCs develop from MMR-proficient adenomas, MMR-deficient adenomas or directly from MMR-deficient crypts. Understanding the specific differences in carcinogenesis for each LS subgroup will aid in the further optimization of guidelines for diagnosis, surveillance and treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Neoplásicas Hereditárias / Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
...